. Author manuscript; available in PMC: 2020 Nov 5.

Published in final edited form as: J Am Med Dir Assoc. 2020 Jun 9;21(11):1617–1622.e3. doi: 10.1016/j.jamda.2020.04.005

Table 2.

Association between the National Partnership and risks of hospitalizations, for residents from all NHs and for residents from NHs with highest/lowest baseline antipsychotic use, after adjusting for individual covariates

	All NHs	NHs with highest antipsychotic%	NHs with lowest antipsychotic%
	(n=565,885)	(n=120,605)	(n=140,952)
ADRD	−0.0179^***	−0.0224^***	−0.0159^***
	(−0.0224 – −0.0134)	(−0.0327 – −0.0121)	(−0.0246 – −0.00721)
Post-Partnership	0.000561	−0.00412	−0.00137
	(−0.00529 – 0.00641)	(−0.0177 – 0.00945)	(−0.0128 – 0.0101)
ADRD * post-Partnership	0.00673^***	0.0121^**	0.00596
	(0.00181 – 0.0116)	(0.000707 – 0.0234)	(−0.00350 – 0.0154)

^**

p<0.05

^***

p<0.01

95% confidence interval in parentheses